Carlyle and SK Capital Partners are buying beleaguered gene therapy biotech Bluebird Bio for about $29 million.

Bluebird bio (BLUE) shares continued their downward descent Monday following news that the company plans to be taken private through a deal valued at up to $96M. Read more here.

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed ...

Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award‑winning leader in drone ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Affinity Equity Partners, the private equity firm that acquired South Korea’s two largest rental car companies, is securing 1 ...

The Town of Leader held its regular council meeting on January 7, with Mayor Aaron Wenzel and Councillors Dustin Heatcoat, ...

AI-driven transformation in telecom is well underway, with network operators pursuing varied AI strategies to improve both ...

Together AI has raised $305 million in its Series B funding round. Self-described as an AI acceleration cloud, Together AI's funding round was led by General Catalyst, and co-led by Prosperity7, with ...

The Saskatchewan Government has announced $6.5 million in funding for the Ronald McDonald House Charities (RMHC). The funding will go towards building Regina's first ever Ronald McDonald House.

Adrian Wojnarowski's Woj Bombs are a thing of the past, but the retired journalist is using the legacy of his league-altering updates to raise capital for the St.

Economist Rehman Sobhan on Monday said that the world of liberalisation and globalisation was now in retreat amid weaponising the tariff by powerful nations, causing concerns for ...